Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tata

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|June 20, 2012
Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetesYusheng Xiong, Jian Guo, Mari R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Discovery of potent, orally active benzimidazole glucagon receptor antagonistsRonald M Kim, Jiang Chang, Ashley R Lins, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2012
Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanineZhicai Wu, Cangming Yang, Yusheng Xiong, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Stem Cell Reports|December 10, 2013
TBX3 Directs Cell-Fate Decision toward MesendodermClair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
Stem Cell Reports|January 13, 2017
TBX3 Directs Cell-Fate Decision toward MesendodermClair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptorJoseph L Duffy, Brian A Kirk, Zenon Konteatis, et al.
Journal of Medicinal Chemistry|April 30, 2004
Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activityAmjad Ali, Christopher F Thompson, James M Balkovec, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|June 20, 2012
Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetesYusheng Xiong, Jian Guo, Mari R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Discovery of potent, orally active benzimidazole glucagon receptor antagonistsRonald M Kim, Jiang Chang, Ashley R Lins, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2012
Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanineZhicai Wu, Cangming Yang, Yusheng Xiong, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Stem Cell Reports|December 10, 2013
TBX3 Directs Cell-Fate Decision toward MesendodermClair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
Stem Cell Reports|January 13, 2017
TBX3 Directs Cell-Fate Decision toward MesendodermClair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptorJoseph L Duffy, Brian A Kirk, Zenon Konteatis, et al.
Journal of Medicinal Chemistry|April 30, 2004
Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activityAmjad Ali, Christopher F Thompson, James M Balkovec, et al.
Pageof 28